These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12463442)

  • 1. Socioeconomic consequences of ankylosing spondylitis.
    Boonen A
    Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S23-6. PubMed ID: 12463442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries.
    Boonen A; van der Heijde D; Landewé R; Spoorenberg A; Schouten H; Rutten-van Mölken M; Guillemin F; Dougados M; Mielants H; de Vlam K; van der Tempel H; van der Linden S
    Ann Rheum Dis; 2002 May; 61(5):429-37. PubMed ID: 11959767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of work-participation, cost-of-illness and cost-effectiveness studies in ankylosing spondylitis.
    Boonen A
    Nat Clin Pract Rheumatol; 2006 Oct; 2(10):546-53. PubMed ID: 17016480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost effectiveness of combined spa-exercise therapy in ankylosing spondylitis: a randomized controlled trial.
    Van Tubergen A; Boonen A; Landewé R; Rutten-Van Mölken M; Van Der Heijde D; Hidding A; Van Der Linden S
    Arthritis Rheum; 2002 Oct; 47(5):459-67. PubMed ID: 12382292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ankylosing spondylitis: what is the cost to society, and can it be reduced?
    Boonen A; Severens JL
    Best Pract Res Clin Rheumatol; 2002 Sep; 16(4):691-705. PubMed ID: 12406435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Socioeconomic impact of ankylosing spondylitis in Tunisia.
    Younes M; Jalled A; Aydi Z; Zrour S; Korbaa W; Ben Salah Z; Letaief M; Bejia I; Touzi M; Bergaoui N
    Joint Bone Spine; 2010 Jan; 77(1):41-6. PubMed ID: 20022534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of ankylosing spondylitis on sick leave, presenteeism and unpaid productivity, and estimation of the societal cost.
    Boonen A; Brinkhuizen T; Landewé R; van der Heijde D; Severens JL
    Ann Rheum Dis; 2010 Jun; 69(6):1123-8. PubMed ID: 20439293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost of care of rheumatoid arthritis and ankylosing spondylitis patients in tertiary care rheumatology units in Turkey.
    Malhan S; Pay S; Ataman S; Dalkilic E; Dinc A; Erken E; Ertenli I; Ertugrul E; Gogus F; Hamuryudan V; Inanc M; Karaarslan Y; Karadag O; Karakoc Y; Keskin G; Kisacik B; Kiraz S; Oksel F; Oksuz E; Pirildar T; Sari I; Soy M; Senturk T; Taylan A
    Clin Exp Rheumatol; 2012; 30(2):202-7. PubMed ID: 22546069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost of illness from the public payers' perspective in patients with ankylosing spondylitis in rheumatological care.
    Strömbeck B; Englund M; Bremander A; Jacobsson LT; Kedza L; Kobelt G; Petersson IF
    J Rheumatol; 2010 Nov; 37(11):2348-55. PubMed ID: 20716657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of the costs of illness of ankylosing spondylitis and methodologic notes.
    Boonen A; van der Heijde D
    Expert Rev Pharmacoecon Outcomes Res; 2005 Apr; 5(2):163-81. PubMed ID: 19807572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthcare costs and productivity losses directly attributable to ankylosing spondylitis.
    Rafia R; Ara R; Packham J; Haywood KL; Healey E
    Clin Exp Rheumatol; 2012; 30(2):246-53. PubMed ID: 22409861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis.
    Boonen A; van den Heuvel R; van Tubergen A; Goossens M; Severens JL; van der Heijde D; van der Linden S
    Ann Rheum Dis; 2005 Mar; 64(3):396-402. PubMed ID: 15271773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs and work limitation of patients with ankylosing spondylitis in China.
    Tu L; Rai JC; Cao S; Lin Z; Hu Z; Gu J
    Clin Exp Rheumatol; 2014; 32(5):661-6. PubMed ID: 25234798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The economic burden of disease: comparison between rheumatoid arthritis and ankylosing spondylitis.
    Boonen A; Mau W
    Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S112-7. PubMed ID: 19822056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resource utilisation and cost of ankylosing spondylitis in Brazil.
    Torres TM; Ferraz MB; Ciconelli RM
    Clin Exp Rheumatol; 2010; 28(4):490-7. PubMed ID: 20810034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-of-illness of rheumatoid arthritis and ankylosing spondylitis.
    Franke LC; Ament AJ; van de Laar MA; Boonen A; Severens JL
    Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S118-23. PubMed ID: 19822057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The burden of ankylosing spondylitis in Spain.
    Kobelt G; Sobocki P; Mulero J; Gratacos J; Pocovi A; Collantes-Estevez E
    Value Health; 2008; 11(3):408-15. PubMed ID: 18489666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Work status and its determinants among patients with ankylosing spondylitis. A systematic literature review.
    Boonen A; de Vet H; van der Heijde D; van der Linden S
    J Rheumatol; 2001 May; 28(5):1056-62. PubMed ID: 11361189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The burden of ankylosing spondylitis.
    Boonen A; van der Linden SM
    J Rheumatol Suppl; 2006 Sep; 78():4-11. PubMed ID: 17042055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany.
    Huscher D; Merkesdal S; Thiele K; Zeidler H; Schneider M; Zink A;
    Ann Rheum Dis; 2006 Sep; 65(9):1175-83. PubMed ID: 16540552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.